- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01800916
Safety and Performance of New 1-piece Ostomy Product
Investigating the Safety and Performance of New 1-piece Ostomy Product Concepts Compared With SenSura 1-piece in Subjects With an Ileostomy
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Humlebæk, Dinamarca, 3050
- Holtedam 3
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Have given written informed consent and signed letter of authority form.
- Be at least 18 years of age and have full legal capacity.
- Be able to handle the bags themselves.
- Have an ileostomy with a diameter between 15 and 40 mm.
- Have had their ostomy for at least three months.
- Currently use a 1-piece flat ostomy appliance with open bag.
- Use minimum 1 ostomy appliance every second day.
- Be suitable for participation in the investigation and for using standard adhesive, flat base plate.
- Must be able to use a custom cut ostomy appliance.
- Accept to test three 1-piece ostomy appliances in the investigation.
- Negative result of a pregnancy test for women of childbearing age (only DK).
Exclusion Criteria:
- Use irrigation during the study (flush the stoma with water).
- Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
- Currently receiving or have within the past months received local or systemic steroid treatment in the peristomal area.
- Are pregnant or breastfeeding.
- Participating in other interventional clinical investigations or have previously participated in this investigation.
- Currently using ostomy belt.
- Currently using extended wear product.
- Known hypersensitivity towards any of the test products
- Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse) -
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Treatment sequence 1
The subjects randomised to Treatment sequence 1 are going to test
The subjects test the three test products in a randomised order: ABS; BSA; SAB |
Coloplast Adhesive baseplate A is a newly developed 1-piece ostomy appliance.
Coloplast Adhesive baseplate B is a newly developed 1-piece ostomy appliance
SenSura 1-piece is the commercial CE-marked Coloplast 1-piece SenSura .
|
|
Experimental: Treatment sequence 2
The subjects randomised to Treatment sequence 2 are going to test
The subjects test the three test products in a randomised order: CBS; BSC; SCB |
Coloplast Adhesive baseplate B is a newly developed 1-piece ostomy appliance
SenSura 1-piece is the commercial CE-marked Coloplast 1-piece SenSura .
Coloplast Adhesive baseplate C is a newly developed 1-piece ostomy appliance
|
|
Experimental: Treatment sequence 3
The subjects randomised to Treatment sequence 3 are going to test
The subjects test the three test products in a randomised order: ACS; CSA; SAC |
Coloplast Adhesive baseplate A is a newly developed 1-piece ostomy appliance.
SenSura 1-piece is the commercial CE-marked Coloplast 1-piece SenSura .
Coloplast Adhesive baseplate C is a newly developed 1-piece ostomy appliance
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Degree of Leakage
Periodo de tiempo: one week
|
The degree of leakage is measured using a 4-point leakage scale developed by Coloplast A/S at every baseplate change. The subjects had to tick off one of the following choices:
|
one week
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Birte Jakobsen, Dr., Coloplast A/S
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- CP236
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .